Brief: Natco Pharma Updates On The Legal Proceedings On Risdiplam In India
17/10/2025 14:12
Oct 17 (Reuters) - Natco Pharma NATP.NS: UPDATES ON THE LEGAL PROCEEDINGS ON RISDIPLAM IN INDIA INDIA'S SUPREME COURT DISMISSED PETITION FILED BY F. HOFFMANN-LA ROCHE AG Source text: [ID:] Further company coverage: NATP.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees